Summary & Overview
HCPCS J1953: Levetiracetam Injection, 10 mg
HCPCS Level II code J1953 designates an injection of levetiracetam, 10 mg. As an HCPCS Level II drug code, it is used on medical claims to identify parenteral administration of the antiepileptic agent levetiracetam in discrete 10 mg units. Accurate coding of J1953 matters nationally because it affects drug utilization reporting, facility and professional reimbursement, and tracking of antiepileptic therapy in acute and ambulatory settings.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the code’s clinical context and common sites of service, plus a summary of typical billing considerations and the kinds of benchmarks and policy updates that influence payment for HCPCS drug codes. The report highlights how J1953 is used across hospital inpatient, outpatient, emergency department, and infusion/clinic settings, and points to where users can find payer-specific coverage rules, billing guidance, and unitization practices.
Data not available in the input: detailed payer-specific rates, associated taxonomies, related codes, and ICD-10 diagnoses. The publication focuses on operational and policy-relevant information to support coding, billing, and administrative decisions at a national level.
Billing Code Overview
HCPCS Level II code J1953 represents an injection of levetiracetam, 10 mg. This code describes a medication administration service in which a 10 mg dose of levetiracetam is provided by injection. The service type is medication administration for an antiepileptic/neurologic agent. The typical site of service for this injectable medication includes hospital inpatient, hospital outpatient, emergency department, and ambulatory infusion or clinic settings where parenteral antiepileptic therapy is administered.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult with a seizure disorder or acute symptomatic seizures who presents to the emergency department or inpatient unit requiring urgent parenteral anticonvulsant therapy. The clinician orders J1953 (injection, levetiracetam, 10 mg) to provide rapid loading or supplemental dosing when the patient cannot take oral medication, is NPO, has vomiting, altered mental status, or requires IV therapy for faster onset. The workflow: triage and assessment by emergency or neurology team, verification of indication and allergies, IV access placement, pharmacy preparation and dose calculation (based on weight and renal function), administration by nursing with vital sign monitoring, documentation of dose, route, time, and response, and follow-up orders for maintenance therapy or transition to oral levetiracetam when safe. Typical sites of service include the emergency department, inpatient medical or neurology ward, intensive care unit, and infusion center for parenteral medication administration.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
11 | Normal day-to-day service | Use when this injection is part of a routine evaluation and management visit without unusual circumstances. |